Video

Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.

Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.

Discover why mass photometry is becoming essential in the toolbox of protein studies.

Advances in analytical instrumentation are helping researchers study drug behavior, improve biomedical research, and train the next generation of scientists.

Living drugs are blurring the line between therapy and biology, challenging decades of assumptions about how medicines are made and controlled.

As the Advanced Therapies sector matures, London brought together global executives, start-ups, and researchers to confront the practical realities of scaling cell and gene therapies

As omics research expands in scale and complexity, advances in mass spectrometry are helping scientists generate deeper, more reliable insights across proteomics, lipidomics, and metabolomics.

Find out how advanced tissue imaging approaches are enabling researchers to connect complex biological data with clinically meaningful outcomes.

 Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.